Portage Capital Stock from 2010 to 2025
PRTG Stock | USD 4.41 0.15 3.29% |
Capital Stock | First Reported 2010-12-31 | Previous Quarter 252.4 M | Current Value 176.2 M | Quarterly Volatility 46.2 M |
Check Portage Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Portage Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 59 K, Other Operating Expenses of 22 M or Total Operating Expenses of 22 M, as well as many indicators such as Price To Sales Ratio of 2 K, Dividend Yield of 0.0 or PTB Ratio of 61.11. Portage financial statements analysis is a perfect complement when working with Portage Biotech Valuation or Volatility modules.
Portage | Capital Stock |
Latest Portage Biotech's Capital Stock Growth Pattern
Below is the plot of the Capital Stock of Portage Biotech over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Portage Biotech's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Portage Biotech's overall financial position and show how it may be relating to other accounts over time.
Capital Stock | 10 Years Trend |
|
Capital Stock |
Timeline |
Portage Capital Stock Regression Statistics
Arithmetic Mean | 144,991,728 | |
Geometric Mean | 139,328,489 | |
Coefficient Of Variation | 31.89 | |
Mean Deviation | 37,538,751 | |
Median | 116,237,000 | |
Standard Deviation | 46,244,192 | |
Sample Variance | 2138.5T | |
Range | 136.2M | |
R-Value | 0.77 | |
Mean Square Error | 924.8T | |
R-Squared | 0.60 | |
Significance | 0.0005 | |
Slope | 7,500,981 | |
Total Sum of Squares | 32077.9T |
Portage Capital Stock History
Other Fundumenentals of Portage Biotech
Portage Biotech Capital Stock component correlations
Click cells to compare fundamentals
About Portage Biotech Financial Statements
Portage Biotech stakeholders use historical fundamental indicators, such as Portage Biotech's Capital Stock, to determine how well the company is positioned to perform in the future. Although Portage Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Portage Biotech's assets and liabilities are reflected in the revenues and expenses on Portage Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Portage Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Capital Stock | 252.4 M | 176.2 M | |
Issuance Of Capital Stock | 6.9 M | 9.9 M |
Currently Active Assets on Macroaxis
EBR | Centrais Electricas Brasileiras | |
HE | Hawaiian Electric Industries | |
VFC | VF Corporation | |
BVHMF | Vistry Group PLC | |
S | SentinelOne |
Check out the analysis of Portage Biotech Correlation against competitors. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Portage Biotech. If investors know Portage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Portage Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Portage Biotech is measured differently than its book value, which is the value of Portage that is recorded on the company's balance sheet. Investors also form their own opinion of Portage Biotech's value that differs from its market value or its book value, called intrinsic value, which is Portage Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Portage Biotech's market value can be influenced by many factors that don't directly affect Portage Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Portage Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Portage Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Portage Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.